// App-Quantinova.ai

3133 : Hyperlipidaemia associated oxidised phospholipids induce sustained platelet hyperactivity by CD36 and PLC gamma 2 dependent ROS production

Researchers

Presenter

  • M. Berger

Principal Investigators

  • K. Wraith

  • A. Aburima

  • C. Woodwaard

  • M. Hindle

  • M. Febbriao

  • K.M. Naseem

Medical Centers

  • University Hospital RWTH Aachen, Department of Palliative Medicine, Aachen, Germany

  • University of Hull, Centre for Cardiovascular & Metabolic Research, Hull, United Kingdom

  • University of Alberta, School of Dentistry, Edmonton, Canada

Locations

  • Germany

  • United Kingdom

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Proto-oncogene tyrosine-protein kinase ROS

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • The Rotations-Program of The Medical faculty of RWTH Aachen University

Result

  • N/A